Form 4: Pacific Biosciences CFO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Susan G. Kim, CFO of Pacific Biosciences, sold 19,782 shares of common stock on September 30, 2024, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On September 30, 2024, Susan G. Kim, the Chief Financial Officer of Pacific Biosciences, sold 19,782 shares of the company's common stock.
- The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
- The shares were sold at a weighted average price ranging from $1.71 to $1.74 per share.
- Following the transaction, Kim directly owns 695,654 shares of Pacific Biosciences stock, which includes 3,176 shares purchased on September 3, 2024, under the company's 2010 Employee Stock Purchase Plan.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover taxes) and doesn't contain any information that would significantly impact investor sentiment positively or negatively.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and are generally not indicative of a negative outlook on the company's future.
Key Dates
| Date | Description |
|---|---|
| September 3, 2024 | Kim purchased 3,176 shares under the company's 2010 Employee Stock Purchase Plan. |
| September 30, 2024 | Kim sold 19,782 shares of common stock to cover tax withholding obligations. |
| October 02, 2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.